Pham Quang X 4
4 · Cadrenal Therapeutics, Inc. · Filed Jun 5, 2026
Research Summary
AI-generated summary of this filing
Cadrenal (CVKD) 10% Owner Pham Quang Sells 8,285 Shares
What Happened
Pham Quang (listed as a 10% owner) sold a total of 8,285 shares of Cadrenal Therapeutics (CVKD) in three open-market transactions between June 3–5, 2026. The trades reported: 2,323 shares on 2026-06-03 at a weighted avg price of $4.26 (≈ $9,896); 3,898 shares on 2026-06-04 at a weighted avg price of $4.41 (≈ $17,190); and 2,064 shares on 2026-06-05 at a weighted avg price of $4.42 (≈ $9,123). Total proceeds across the three days were roughly $36,209. These were sales (not purchases), often considered routine dispositions.
Key Details
- Transaction dates and reported weighted-average prices:
- 2026-06-03: 2,323 sh @ $4.26 (weighted avg; underlying trades ranged $4.18–$4.39)
- 2026-06-04: 3,898 sh @ $4.41 (weighted avg; underlying trades ranged $4.19–$4.47)
- 2026-06-05: 2,064 sh @ $4.42 (weighted avg; underlying trades ranged $4.25–$4.50)
- Total shares sold: 8,285; total proceeds ≈ $36,209.
- Shares owned after the transactions: not specified in the provided summary — see the full Form 4 for post-transaction holdings.
- Notable footnotes:
- Sales were made under a Rule 10b5-1 trading plan adopted Sept 25, 2025 (F1).
- Weighted-average prices and intra-day price ranges are disclosed (F2–F4); issuer or SEC staff can request detailed breakouts.
- F5 notes Pham is trustee of The PVBQ Living Trust and has sole voting/dispositive power over trust shares.
- Filing timeliness: Form filed on 2026-06-05 covering trades through 2026-06-05 — appears to have been filed within the usual Form 4 reporting window.
Context
These transactions are sales by a 10% beneficial owner and were executed under a prearranged 10b5‑1 plan, which typically documents timing and amounts in advance. Sales by large holders can reflect portfolio management rather than a view on company prospects; they are not the same signal as an executive purchase. For full ownership details and exact per-trade prices, consult the complete SEC Form 4 (Accession: 0001213900-26-065925).
Insider Transaction Report
- Sale
Common Stock
[F1][F2]2026-06-03$4.26/sh−2,323$9,896→ 179,186 total - Sale
Common Stock
[F1][F3]2026-06-04$4.41/sh−3,898$17,190→ 175,288 total - Sale
Common Stock
[F1][F4]2026-06-05$4.42/sh−2,064$9,123→ 173,224 total
- 200,000(indirect: By Trust)
Common Stock
[F5]
Footnotes (5)
- [F1]Represents shares of the Issuer's common stock sold by the Reporting Person in accordance with a Rule 10b5-1 trading arrangement adopted by the Reporting Person on September 25, 2025.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.18 through $4.39. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F3]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.19 through $4.47. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $4.25 through $4.50. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the Staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
- [F5]Quang Pham is the Trustee of The PVBQ Living Trust and has sole voting and dispositive power with respect to the shares owned by The PVBQ Trust, of which Mr. Pham's child is the sole beneficiary.